Smith Group Asset Management, LLC Corcept Therapeutics Inc Transaction History
Smith Group Asset Management, LLC
- $1.53 Trillion
- Q2 2025
A detailed history of Smith Group Asset Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Smith Group Asset Management, LLC holds 9,019 shares of CORT stock, worth $708,893. This represents 0.04% of its overall portfolio holdings.
Number of Shares
9,019
Previous 9,019
-0.0%
Holding current value
$708,893
Previous $1.03 Billion
35.74%
% of portfolio
0.04%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding CORT
# of Institutions
474Shares Held
83.5MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.3 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$761 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$607 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$493 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$304 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.42B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...